Tech Mahindra and Wipro have tumbled over 30 per cent, while Apollo Hospitals Enterprise and Dr. Reddy's Laboratories have plummeted 22 per cent so far in calendar year 2022 (CY22)
The derivative analyst from HDFC Securities recommends buying Infy 1,600 Call and simultaneously selling 1,640 Call for the May expiry.
Qualcomm, Infina and Exim Bank also participated in the funding round for company that serves Indian security forces
India has become a battlefield for some global retail behemoths that are either shut out of China or are struggling to compete with local rivals there
The process runs unabated on a loop for large parts of the year, aided by online platforms
Eight of the top-10 most valued firms together lost Rs 2,21,555.61 crore from their market valuation last week, with Infosys and HDFC Bank suffering the biggest hit.
Is invoking a non-compete clause to retain employees right? Will India become a hub for traditional healing? What are investors thinking about the market? Why foreign defaults await Russia? Allnswers
A workers' union has shot off a letter to the govt alleging Infosys of using a non-compete clause to prevent employees from joining rival firms. What's behind the clause? Can it set a wrong precedence
Infosys Chief Executive Officer and Managing Director Salil Parekh said the guidance of 13-15 per cent is the strongest ever for the company at the start of a financial year (2022-23)
NITES has raised a complaint against IT giant Infosys with the Centre over the contract guidelines for restricting former employees from working with competitor
Infosys has said that the situation in Ukraine has not impacted the demand environment when it comes to European clients, and the company will see over the next few quarters on how things pan out.
In early trade, the stock had climbed 3% after the company registered a 49.1% jump in consolidated net profit in the fourth quarter of FY22
Infy's weak numbers triggers selloff in other IT shares
CLOSING BELL: Dismal March quarter earnings by HDFC Bank & Infosys, coupled with fears of aggressive rate hikes amid rising inflation, soaring bond yields, & resurgence in Covid-19 cases hit sentiment
In Monday's early trade, the two frontline indices dropped 2 per cent each as IT major Infosys and banking giant HDFC Bank plunged sharply on disappointing Q4 performance
The NSE Nifty 50 index fell 1.89% to 17,142.50, as of 0445 GMT, while the S&P BSE Sensex slid 2.15% to 57,089.44
ICICI Prudential Life Insurance seems to be headed towards the 200-DMA, while Infosys and HDFC Bank need to be monitored closely over the next few trading sessions.
Shares of Infosys tanked 9 per cent to Rs 1,592.05 on the BSE in Monday's intra-day trade after the company reported a weak set of numbers for the quarter ended March 2022 (Q4FY22).
The Infosys ADR has declined over 9 per cent in the last two trading session in the US market, while our market was shut for trade, post Q4 results.
The Bengaluru-based IT major saw its revenue rise 23 per cent to Rs 32,276 crore in the recently concluded quarter, as against Rs 26,311 crore in the previous corresponding period